In CCH mice, hippocampal irisin levels declined earlier than serum levels, and increased endogenous irisin levels were positively correlated with improvements in cognitive function, hypokinetic behavior, and anxiety- and depression-like behaviors, indicating the potential of central irisin as an early biomarker for predicting VaD. The gene discussed is FNDC5; the disease is depressive disorder.